1. Черных И.В, Щулькин А.В., Якушева Е.Н., Попова Н.М. Роль гликопротеина-P в неврологии // Журнал неврологии и психиатрии С.С. Корсакова. - 2017. - Т. 117, № 1. - С. 67-71. https://doi.org/10.17116/jnevro20171171167-71.
2. Paul S., Candelario-Jalil E. Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies // Exp. Neurol. - 2021. - Vol. 335. - Art. No.113518. https://doi.org/10.1016/j.expneurol.2020.113518.
3. Lee C., Choi J., Choi D. Effects of pravastatin on the pharmacokinetic parameters of nimodipine after oral and intravenous administration in rats: Possible role of CYP3A4 inhibition by pravastatin // Indian J. Pharmacol. - 2012. - Vol. 44, No.5. - P. 624-628. https://doi.org/10.4103/0253-7613.100395.
4. Mohamed L.A., Keller J.N., Kaddoumi A. Role of P-glycoprotein in mediating rivastigmine effect on amyloid-β brain load and related pathology in Alzheimer’s disease mouse model // Biochim. Biophys. Acta. - 2016. - Vol. 1862, No.4. - P. 778-787. https://doi.org/10.1016/j.bbadis.2016.01.013.
5. Cacabelos R. Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia // Int. J. Mol. Sci. - 2020. - Vol. 21. - Art. No.3059. https://doi.org/10.3390/ijms21093059.
6. Powers W.J., Rabinstein A.A., Ackerson T., Adeoye O.M., Bambakidis N.C., Becker K., Biller J., Brown M., Demaerschalk B.M., Hoh B., Jauch E.C., Kidwell C.S., Leslie-Mazwi T.M., Ovbiagele B., Scott P.A., Sheth K.N., Southerland A.M., Summers D.V., Tirschwell D.L. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association // Stroke. - 2019. - Vol. 50, No.12. - P. e344-e418. https://doi.org/10.1161/STR.0000000000000211. Epub 2019 Oct 30. Erratum in: Stroke. - 2019. - Vol. 50, No.12. - P. e440-e441.
7. Williams E.I., Betterton R.D., Davis T.P., Ronaldson P.T. Transporter-Mediated Delivery of Small Molecule Drugs to the Brain: A Critical Mechanism That Can Advance Therapeutic Development for Ischemic Stroke // Pharmaceutics. - 2020. - Vol. 154, No.12. - Art. No.154. https://doi.org/10.3390/pharmaceutics12020154.
8. Cen J., Liu L., Li M.S., He L., Wang L.J., Liu Y.Q., Liu M., Ji B.S. Alteration in P-glycoprotein at the blood-brain barrier in the early period of MCAO in rats // J. Pharm. Pharmacol. - 2013. - Vol. 65. - P. 665-672. https://doi.org/10.1111/jphp.12033.
9. Черных И.В., Якушева Е.Н., Щулькин А.В., Виноградов И.Ю., Титов Д.С. Экспрессия гликопротеина-P в гематоэнцефалическом барьере при двухсторонней окклюзии общих сонных артерий // Научные ведомости Белгородского государственного университета. - 2015.
10. - Т. 29, № 4(201). - С. 91-95.
11. Самородская И.В., Андреев Е.М., Заратьянц О.В. Показатели смертности населения старше 50 лет от цереброваскулярных болезней за 15-летний период в России и США // Неврология, нейропсихиатрия и психосоматика. - 2017. - Т. 9, № 1. - С. 15-24. https://doi.org/10.14412/2074-2711-2017-2-15-24.
12. Yang S.H., Shetty R.A., Liu R., Sumien N., Heinrich K.R., Rutledge M., Thangthaeng N., Brun-Zinkernagel A.M., Forster M.J. Endovascular middle cerebral artery occlusion in rats as a model for studying vascular dementia // Age (Dordr). - 2006. - Vol. 28, No.3. - P. 297-230. https://doi.org/10.1007/s11357-006-9026-4.
13. Ye X.L., Lu L.Q., Li W., Lou Q., Guo H.G., Shi Q.J. Oral administration of ampelopsin protects against acute brain injury in rats following focal cerebral ischemia // Exp. Ther. Med. - 2017. - Vol. 13. - P. 1725−1734. https://doi.org/10.3892/etm.2017.4197.
14. Khaksar S., Bigdeli M.R. Correlation Between Cannabidiol-Induced Reduction of Infarct Volume and Inflammatory Factors Expression in Ischemic Stroke Model. Basic Clin Neurosci. - 2017. No.8(2). P. 139−146. https://doi.org/10.18869/nirp.bcn.8.2.139.
15. Wang X., Wang C., Yang Y., Ni J. New monocyte locomotion inhibitory factor analogs protect against cerebral ischemia-reperfusion injury in rats // Bosn J Basic Med Sci. - 2017. - Vol. 17, No.3. - P. 221-227. https://doi.org/10.17305/bjbms.2017.1622.
16. Leisz S., Simmermacher S., Prell J., Strauss С., Scheller С. Nimodipine-Dependent Protection of Schwann Cells, Astrocytes and Neuronal Cells from Osmotic, Oxidative and Heat Stress Is Associated with the Activation of AKT and CREB // Int. J. Mol. Sci. - 2019. - Vol. 20, No.18. - Art. No.4578. https://doi.org/10.3390/ijms20184578.
17. Regardh C.J., Gabrielsson M., Hoffman K.J., Lofberg I., Skanberg I. Pharmacokinetics and metabolism of omeprazole in animals and man − an overview // Scand. J. Gastroenterol. Suppl. - 1985. - Vol. 108. - P. 79-94. https://doi.org/10.3109/00365528509095821.
18. Shah Y., Iqbal Z., Ahmad L., Khuda F., Khan A., Khan A., Khan M.I., Ismail. Effect of Omeprazole on the Pharmacokinetics of Rosuvastatin in Healthy Male Volunteers // Am. J. Ther. - 2016. - Vol. 23, No.6. - P. e1514-e1523. https://doi.org/10.1097/MJT.0000000000000221.
19. Andersson T., Cederberg C., Heggelund A. et al. The Pharmacokinetics of Single and Repeated Once-Daily Doses of 10, 20 and 40mg Omeprazole as Enteric-Coated Granules // Drug Invest. - 1991. - Vol. 3. - P. 45-52. https://doi.org/10.1007/BF03259540.
20. Khojasteh S.C., Prabhu S., Kenny J.R., Halladay J.S., Lu A.Y. Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity // Eur. J. Drug. Metab. Pharmacokinet. - 2011. - Vol. 36, No.1. - P. 1-16. https://doi.org/10.1007/s13318-011-0024-2.
21. Liu X.Q., Ren Y.L., Qian Z.Y., Wang G.J. Enzyme kinetics and inhibition of nimodipine metabolism in human liver microsomes // Acta Pharmacol. Sin. - 2000. - Vol. 21, No.8. - P. 690-694.
22. Xu L., Fagan S.C., Waller J.L., Edwards D., Borlongan C.V., Zheng J., Hill W.D., Feuerstein G., Hess D.C. Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats // BMC Neurol. - 2004. - Vol. 4. - Art. No.7. https://doi.org/10.1186/1471-2377-4-7.
23. Jin Z., Ke J., Guo P., Wang Y., Wu H. Quercetin improves blood-brain barrier dysfunction in rats with cerebral ischemia reperfusion via Wnt signaling pathway // Am. J. Transl. Res. - 2019. - Vol. 11, No.8. - P. 4683-4695.
24. Washida K., Hattori Y., Ihara M. Animal Models of Chronic Cerebral Hypoperfusion: From Mouse to Primate. Int. J. Mol. Sci. - 2019. - Vol. 20, No.24. - Art. No.6176. https://doi.org/10.3390/ijms20246176.
25. Li W., Suwanwela N.C., Patumraj S. Curcumin prevents reperfusion injury following ischemic stroke in rats via inhibition of NF κB, ICAM-1, MMP-9 and caspase-3 expression // Mol. Med. Rep. - 2017. - Vol. 16, No.4. - P. 4710-4720. https://doi.org/10.3892/mmr.2017.7205.
26. Feng B., Mills J.B., Davidson R.E., Mireles R.J., Janiszewski J.S., Troutman M.D., de Morais S.M. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system // Drug Metab. Dispos. - 2008. - Vol. 36, No.2. - P. 268-275. https://doi.org/10.1124/dmd.107.017434.
27. Tournier N., Goutal S., Auvity S., Traxl A., Mairinger S., Wanek T., Helal O.B., Buvat I., Soussan M., Caillé F., Langer O. Strategies to Inhibit ABCB1- and ABCG2-Mediated Efflux Transport of Erlotinib at the Blood-Brain Barrier: A PET Study on Nonhuman Primates // J. Nucl. Med. - 2017. - Vol. 58, No.1. - P. 117-122. https://doi.org/10.2967/jnumed.116.178665.
28. Damont A., Goutal S., Auvity S., Valette H., Kuhnast B., Saba W., Tournier N. Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [(11)C]-N-desmethyl-loperamide PET study in nonhuman primates // Eur. J. Pharm. Sci. - 2016. - Vol. 91. - P. 98-104. https://doi.org/10.1016/j.ejps.2016.06.005.
29. Черных И.В., Щулькин А.В., Якушева Е.Н., Есенина А.С., Градинарь М.М., Мыльников П.Ю., Гацанога М.В. Функциональная активность гликопротеина-P в гематоэнцефалическом барьере на фоне ишемии-реперфузии головного мозга // Российский физиологический журнал им. И.М. Сеченова. - 2019. - Т. 105, № 5. - С. 657-664. https://doi.org/10.1134/S0869813919050133.